SYNOPSYS, INC. (SNPS) FY2026 YTD Q3 P&L / Income Statement
2025-11-01 to 2026-07-31
Revenue by Business Segment
2025-11-01 to 2026-07-31
Swipe to see the full flow
Chart details
SYNOPSYS, INC. (SNPS) FY2026 YTD Q3 P&L / Income Statement
Income statement for 2025-11-01 through 2026-07-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Total revenue
- 7,161,605,000 US dollars
- Total cost of revenue
- 1,946,620,000 US dollars
- Gross margin
- 5,214,985,000 US dollars
- Total operating expenses
- 4,534,022,000 US dollars
- Operating income
- 680,963,000 US dollars
- Other income (expense), net (calculated)
- 101,288,000 US dollars
- Income before income taxes
- 782,251,000 US dollars
- Provision (benefit) for income taxes
- 154,961,000 US dollars
- Net income
- 627,290,000 US dollars
- Design Automation
- 5,826,565,000 US dollars
- Design IP
- 1,335,040,000 US dollars
- Research and development
- 2,134,849,000 US dollars
- Sales and marketing
- 1,164,262,000 US dollars
- General and administrative
- 532,129,000 US dollars
- Amortization of acquired intangible assets
- 466,442,000 US dollars
- Restructuring charges
- 236,340,000 US dollars
- Loss from discontinued operations, net of income taxes
- 0 US dollars. Reported below-tax contribution to net income.
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
- Of which attributable to SYNOPSYS, INC.: $627.86 M; to noncontrolling interests: −$573.00 K.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
72.8%
Gross profit / revenue
Operating margin
9.5%
Operating profit / revenue
Cash conversion
366.4%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
